Article Versions Notes

Iemmolo R, La Cognata V, Morello G, Guarnaccia M, Arbitrio M, Alessi E, Cavallaro S. Development of a Pharmacogenetic Lab-on-Chip Assay Based on the In-Check Technology to Screen for Genetic Variations Associated to Adverse Drug Reactions to Common Chemotherapeutic Agents. Biosensors. 2020; 10(12):202. https://doi.org/10.3390/bios10120202

Iemmolo, Rosario, Valentina La Cognata, Giovanna Morello, Maria Guarnaccia, Mariamena Arbitrio, Enrico Alessi, and Sebastiano Cavallaro. 2020. "Development of a Pharmacogenetic Lab-on-Chip Assay Based on the In-Check Technology to Screen for Genetic Variations Associated to Adverse Drug Reactions to Common Chemotherapeutic Agents" Biosensors 10, no. 12: 202. https://doi.org/10.3390/bios10120202

Iemmolo, R., La Cognata, V., Morello, G., Guarnaccia, M., Arbitrio, M., Alessi, E., & Cavallaro, S. (2020). Development of a Pharmacogenetic Lab-on-Chip Assay Based on the In-Check Technology to Screen for Genetic Variations Associated to Adverse Drug Reactions to Common Chemotherapeutic Agents. Biosensors, 10(12), 202. https://doi.org/10.3390/bios10120202